PD-1 and CTLA-4 are expressed on T cells during priming and activation, while in the tumor microenvironment (TME), local interferon-gamma (IFNγ), mainly derived from effector lymphocytes, induces the expression of PD-L1 on cancer cells and intra-tumoral immune cells. This evidence concerns the gene PDCD1 and neoplasm.